What
Where
52.212-4(C) CONTRACT TERMS AND CONDITIONS - CHANGES UPDATE TO COST RECOVERY FEE (CRF) AND SUBMISSION OF QUARTERLY SALES REPORTS 36E79724D0014 EXELAN PHARMACEUTI...
From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date17 Mar, 2024 (1 month ago) Due Date16 Mar, 2025 (in 10 months) TypeContractIdentifier36E79723R0025 | ||||
 Customer / Agency | VETERANS AFFAIRS, DEPARTMENT OF | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
52.212-4(C) CONTRACT TERMS AND CONDITIONS - CHANGES UPDATE TO COST RECOVERY FEE (CRF) AND SUBMISSION OF QUARTERLY SALES REPORTS 36E79724D0014 EXELAN PHARMACEUTICALS, INC. ESCITALOPRAM OXALATE TABLETS Solicitation ID/Procurement Identifier: 36E79723R0025 Ultimate Completion Date: Sun Mar 16 17:00:00 GMT
Location
Address: 370 CAMINO GARDENS BLVD,BOCA RATON,USA
Country : United StatesYou may also like
NEW AWARD FOR EZETIMIBE TABLETS WITH MARLEX PHARMACEUTICALS. PERIOD OF PERFORMANCE IS APRIL 28, 2024 - APRIL 27, 2025 WITH FOUR ONE-YEAR OPTIONS
Due: 27 Apr, 2025 (in 12 months)AWARD TO RADHA PHARMACEUTICALS INC FOR GABAPENTIN TABLETS FOR THE BASE YEAR WITH FOUR ONE-YEAR OPTIONS.
Due: 31 Dec, 2024 (in 8 months)NEW AWARD FOR ACALABRUTINIB TABLETS (100 MG) WITH ASTRAZENECA PHARMACEUTICALS, LP. PERIOD OF PERFORMANCE IS 06/24/2024 TO 06/23/2025 WITH FOUR ONE-YEAR OPTIONS.
Due: 23 Jun, 2025 (in 13 months)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.